<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35579435</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Chemokine PF4 Inhibits EV71 and CA16 Infections at the Entry Stage.</ArticleTitle><Pagination><StartPage>e0043522</StartPage><MedlinePgn>e0043522</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00435-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00435-22</ELocationID><Abstract><AbstractText>Platelet factor 4 (PF4) or the CXC chemokine CXCL4 is the most abundant protein within the &#x3b1;-granules of platelets. Previous studies found that PF4 regulates infections of several viruses, including HIV-1, H1N1, hepatitis C virus (HCV), and dengue virus. Here, we show that PF4 is an inhibitor of enterovirus A71 (EV71) and coxsackievirus A16 (CA16) infections. The secreted form of PF4 from transfected cells or soluble purified PF4 from Escherichia coli, even lacking signal peptide affected secretion, obviously inhibited the propagation of EV71 and CA16. Mechanistically, we demonstrated that PF4 blocked the entry of the virus into the host cells by interactions with VP3 proteins of EV71/CA16 and the interaction with SCARB2 receptor-mediated EV71 and CA16 endocytosis. As expected, the incubation of anti-PF4 antibody with PF4 blocked PF4 inhibition on EV71 and CA16 infections further supported the above conclusion. Importantly, pretreatment of EV71 viruses with PF4 significantly protected the neonatal mice from EV71 lethal challenge and promoted the survival rate of infected mice. PF4 derived from natural platelets by EV71/CA16 activation also presented strong inhibition on EV71 and CA16. In summary, our study identified a new host factor against EV71 and CA16 infections, providing a novel strategy for EV71 and CA16 treatment. <b>IMPORTANCE</b> The virus's life cycle starts with binding to cell surface receptors, resulting in receptor-mediated endocytosis. Targeting the entry of the virus into target cells is an effective strategy to develop a novel drug. EV71 and CA16 are the major pathogens that cause hand, foot, and mouth disease (HFMD) outbreaks worldwide since 2008. However, the treatment of EV71 and CA16 infections is mainly symptomatic because there is no approved drug. Therefore, the underlying pathogenesis of EV71/CA16 and the interaction between host-EV71/CA16 need to be further investigated to develop an inhibitor. Here, we identified PF4 as a potent entry inhibitor of EV71 and CA16 via binding to VP3 proteins of EV71 and CA16 or binding to receptor SCARB2. In the EV71 infection model, PF4 protected mice from EV71 lethal challenge and promoted the survival rate of EV71-infected mice. Our study suggests that PF4 represents a potential candidate host factor for anti-EV71 and CA16 infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pei</LastName><ForeName>Zhichao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhilei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huan</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenyan</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4507-521X</Identifier><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>37270-94-3</RegistryNumber><NameOfSubstance UI="D010978">Platelet Factor 4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010978" MajorTopicYN="Y">Platelet Factor 4</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="Y">Virus Internalization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PF4</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">entry inhibition</Keyword><Keyword MajorTopicYN="N">platelet activation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35579435</ArticleId><ArticleId IdType="pmc">PMC9175630</ArticleId><ArticleId IdType="doi">10.1128/jvi.00435-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Handin RI, Cohen HJ. 1976. Purification and binding properties of human platelet factor four. J Biol Chem 251:4273&#x2013;4282. 10.1016/S0021-9258(17)33292-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)33292-1</ArticleId><ArticleId IdType="pubmed">819438</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine SP, Wohl H. 1976. Human platelet factor 4: purification and characterization by affinity chromatography. Purification of human platelet factor 4. J Biol Chem 251:324&#x2013;328. 10.1016/S0021-9258(17)33882-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)33882-6</ArticleId><ArticleId IdType="pubmed">812871</ArticleId></ArticleIdList></Reference><Reference><Citation>Broos K, Feys HB, De Meyer SF, Vanhoorelbeke K, Deckmyn H. 2011. Platelets at work in primary hemostasis. Blood Rev 25:155&#x2013;167. 10.1016/j.blre.2011.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2011.03.002</ArticleId><ArticleId IdType="pubmed">21496978</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemetson KJ. 2012. Platelets and primary haemostasis. Thromb Res 129:220&#x2013;224. 10.1016/j.thromres.2011.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2011.11.036</ArticleId><ArticleId IdType="pubmed">22178577</ArticleId></ArticleIdList></Reference><Reference><Citation>Gawaz M, Vogel S. 2013. Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. Blood 122:2550&#x2013;2554. 10.1182/blood-2013-05-468694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-05-468694</ArticleId><ArticleId IdType="pubmed">23963043</ArticleId></ArticleIdList></Reference><Reference><Citation>Golebiewska EM, Poole AW. 2015. Platelet secretion: from haemostasis to wound healing and beyond. Blood Rev 29:153&#x2013;162. 10.1016/j.blre.2014.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2014.10.003</ArticleId><ArticleId IdType="pmc">PMC4452143</ArticleId><ArticleId IdType="pubmed">25468720</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings LK. 2009. Role of platelets in atherothrombosis. Am J Cardiol 103:4A&#x2013;10A. 10.1016/j.amjcard.2008.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2008.11.017</ArticleId><ArticleId IdType="pubmed">19166707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan ZS, Jackson SP. 2011. The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program 2011:51&#x2013;61. 10.1182/asheducation-2011.1.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/asheducation-2011.1.51</ArticleId><ArticleId IdType="pubmed">22160012</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabrkhany S, Griffioen AW, Oude Egbrink MG. 2011. The role of blood platelets in tumor angiogenesis. Biochim Biophys Acta 1815:189&#x2013;196. 10.1016/j.bbcan.2010.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2010.12.001</ArticleId><ArticleId IdType="pubmed">21167916</ArticleId></ArticleIdList></Reference><Reference><Citation>Semple JW, Italiano JE, Jr, Freedman J. 2011. Platelets and the immune continuum. Nat Rev Immunol 11:264&#x2013;274. 10.1038/nri2956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2956</ArticleId><ArticleId IdType="pubmed">21436837</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas MR, Storey RF. 2015. The role of platelets in inflammation. Thromb Haemost 114:449&#x2013;458. 10.1160/TH14-12-1067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH14-12-1067</ArticleId><ArticleId IdType="pubmed">26293514</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh TG, Metharom P, Berndt MC. 2015. The functional role of platelets in the regulation of angiogenesis. Platelets 26:199&#x2013;211. 10.3109/09537104.2014.909022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09537104.2014.909022</ArticleId><ArticleId IdType="pubmed">24832135</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Bisht P, Bhattacharya S, Guchhait P. 2020. Role of platelet cytokines in dengue virus infection. Front Cell Infect Microbiol 10:561366. 10.3389/fcimb.2020.561366.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.561366</ArticleId><ArticleId IdType="pmc">PMC7554584</ArticleId><ArticleId IdType="pubmed">33102253</ArticleId></ArticleIdList></Reference><Reference><Citation>Auerbach DJ, Lin Y, Miao H, Cimbro R, Difiore MJ, Gianolini ME, Furci L, Biswas P, Fauci AS, Lusso P. 2012. Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor. Proc Natl Acad Sci USA 109:9569&#x2013;9574. 10.1073/pnas.1207314109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1207314109</ArticleId><ArticleId IdType="pmc">PMC3386099</ArticleId><ArticleId IdType="pubmed">22645343</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Feng K, Wang YC, Mei JJ, Ning RT, Zheng HW, Wang JJ, Worthen GS, Wang X, Song J, Li QH, Liu LD. 2017. Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection. Mucosal Immunol 10:1529&#x2013;1541. 10.1038/mi.2017.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2017.1</ArticleId><ArticleId IdType="pubmed">28120850</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Z, Rao J, Xie Z, Wang C, Xu B, Qian S, Wang Y, Zhu J, Yang B, Xu F, Lei X, Guo F, Zhao Z, Ren L, Wang J. 2020. Chemokine (C-X-C Motif) ligand 4 is a restrictor of respiratory syncytial virus infection and an indicator of clinical severity. Am J Respir Crit Care Med 202:717&#x2013;729. 10.1164/rccm.201908-1567OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201908-1567OC</ArticleId><ArticleId IdType="pubmed">32543879</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojha A, Bhasym A, Mukherjee S, Annarapu GK, Bhakuni T, Akbar I, Seth T, Vikram NK, Vrati S, Basu A, Bhattacharyya S, Guchhait P. 2019. Platelet factor 4 promotes rapid replication and propagation of dengue and Japanese encephalitis viruses. EBioMedicine 39:332&#x2013;347. 10.1016/j.ebiom.2018.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.049</ArticleId><ArticleId IdType="pmc">PMC6354622</ArticleId><ArticleId IdType="pubmed">30527622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojha A, Nandi D, Batra H, Singhal R, Annarapu GK, Bhattacharyya S, Seth T, Dar L, Medigeshi GR, Vrati S, Vikram NK, Guchhait P. 2017. Platelet activation determines the severity of thrombocytopenia in dengue infection. Sci Rep 7:41697. 10.1038/srep41697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41697</ArticleId><ArticleId IdType="pmc">PMC5282509</ArticleId><ArticleId IdType="pubmed">28139770</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker ZF, Rux AH, Riblett AM, Lee FH, Rauova L, Cines DB, Poncz M, Sachais BS, Doms RW. 2016. Platelet factor 4 inhibits and enhances HIV-1 infection in a concentration-dependent manner by modulating viral attachment. AIDS Res Hum Retroviruses 32:705&#x2013;717. 10.1089/AID.2015.0344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/AID.2015.0344</ArticleId><ArticleId IdType="pmc">PMC4931766</ArticleId><ArticleId IdType="pubmed">26847431</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzkopff F, Grimm TA, Lankford CS, Fields K, Wang J, Brandt E, Clouse KA. 2009. Platelet factor 4 (CXCL4) facilitates human macrophage infection with HIV-1 and potentiates virus replication. Innate Immun 15:368&#x2013;379. 10.1177/1753425909106171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753425909106171</ArticleId><ArticleId IdType="pubmed">19773294</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99:13&#x2013;22. 10.1016/s0092-8674(00)80058-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)80058-6</ArticleId><ArticleId IdType="pubmed">10520990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam IC, Chan YF. 2013. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol 87:611&#x2013;620. 10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Strating J, van Kuppeveld FJM. 2018. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 16:368&#x2013;381. 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DM, Zhang Y, Scheuermann RH. 2020. Epidemiology and sequence-based evolutionary analysis of circulating non-polio enteroviruses. Microorganisms 8:1856. 10.3390/microorganisms8121856.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8121856</ArticleId><ArticleId IdType="pmc">PMC7759938</ArticleId><ArticleId IdType="pubmed">33255654</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Zhao Y, Kotecha A, Fry EE, Kelly JT, Wang X, Rao Z, Rowlands DJ, Ren J, Stuart DI. 2019. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat Microbiol 4:414&#x2013;419. 10.1038/s41564-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M, Wang X, Wang Q, Wang Y, Lin J, Sun Y, Li X, Zhang L, Lou Z, Wang J, Rao Z. 2014. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell 5:692&#x2013;703. 10.1007/s13238-014-0087-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0087-3</ArticleId><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, Nishimura H, Sanjoh K, Katsushima N, Itagaki T, Nagai Y, Fujii K, Koike S. 2012. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol 86:5686&#x2013;5696. 10.1128/JVI.00020-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00020-12</ArticleId><ArticleId IdType="pmc">PMC3347270</ArticleId><ArticleId IdType="pubmed">22438546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Koike S. 2020. Cellular receptors for enterovirus A71. J Biomed Sci 27:23. 10.1186/s12929-020-0615-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 15:794&#x2013;797. 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. 2011. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol 85:11809&#x2013;11820. 10.1128/JVI.00297-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Guo H, Chang J, Yu Y, Liu G, Zhang N, Willard SH, Zheng S, Yu XF. 2016. ICAM-5/telencephalin is a functional entry receptor for enterovirus D68. Cell Host Microbe 20:631&#x2013;641. 10.1016/j.chom.2016.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.09.013</ArticleId><ArticleId IdType="pubmed">27923705</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J, Li J, Wei W, Liu X, Liu G, Yang J, Zhang W, Yu XF. 2015. Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model. Immunol Res 62:306&#x2013;315. 10.1007/s12026-015-8661-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-015-8661-1</ArticleId><ArticleId IdType="pubmed">26025091</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Chang J, Liu X, Yang J, Guo H, Wei W, Zhang W, Yu XF. 2014. Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates. J Gen Virol 95:1083&#x2013;1093. 10.1099/vir.0.063560-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.063560-0</ArticleId><ArticleId IdType="pmc">PMC3983757</ArticleId><ArticleId IdType="pubmed">24496826</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X, Wan Z, Li Y, Hu Y, Jin X, Zhang C. 2020. National epidemiology and evolutionary history of four hand, foot and mouth disease-related enteroviruses in China from 2008 to 2016. Virol Sin 35:21&#x2013;33. 10.1007/s12250-019-00169-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-019-00169-2</ArticleId><ArticleId IdType="pmc">PMC7035399</ArticleId><ArticleId IdType="pubmed">31664644</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Li L, Ren L, Guo L, Xie Z, Liu C, Li T, Luo M, Paranhos-Baccala G, Xu W, Wang J. 2017. Seroepidemiology of enterovirus D68 infection in China. Emerg Microbes Infect 6:e32. 10.1038/emi.2017.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2017.14</ArticleId><ArticleId IdType="pmc">PMC5520479</ArticleId><ArticleId IdType="pubmed">28487560</ArticleId></ArticleIdList></Reference><Reference><Citation>Anasir MI, Zarif F, Poh CL. 2021. Antivirals blocking entry of enteroviruses and therapeutic potential. J Biomed Sci 28:10. 10.1186/s12929-021-00708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-021-00708-8</ArticleId><ArticleId IdType="pmc">PMC7811253</ArticleId><ArticleId IdType="pubmed">33451326</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu N, Yang J, Zheng B, Zhang Y, Cao Y, Huan C, Wang S, Chang J, Zhang W. 2020. The Pyrimidine analog FNC potently inhibits the replication of multiple enteroviruses. J Virol 94:e00204-20. 10.1128/JVI.00204-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00204-20</ArticleId><ArticleId IdType="pmc">PMC7163137</ArticleId><ArticleId IdType="pubmed">32075935</ArticleId></ArticleIdList></Reference><Reference><Citation>He QQ, Ren S, Xia ZC, Cheng ZK, Peng NF, Zhu Y. 2018. Fibronectin facilitates enterovirus 71 infection by mediating viral entry. J Virol 92:e02251-17. 10.1128/JVI.02251-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02251-17</ArticleId><ArticleId IdType="pmc">PMC5899198</ArticleId><ArticleId IdType="pubmed">29467312</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>